Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Discover the difference between burnout vs depression, including causes, symptoms, and how both are treated, according to ...
Even light-intensity activities such as walking can reduce one’s risk for clinical depression. So, what are the most common ...
Depression can be treated but the first step is determining whether symptoms are present. This test could help. Using the key below, answer the questions based on how strongly you agree or ...
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
Johnson & Johnson has received FDA approval for Spravato nasal spray as the first and only monotherapy for adults with treatment-resistant depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback